stock ticker hero image

Investor relations

Our science-led strategy is key to delivering long-term value for patients, employees and shareholders.

January 26, 2021 8:58 pm ET
Delayed at least 20 minutes

View stock information

Latest news, events & financials

View all

Our pipeline shows our relentless pursuit of the next breakthrough.

Phase II programs
Phase III programs
Under review
Merck leadership team at investor event

Our leadership

Our deep bench of talent has the knowledge, commitment and expertise to successfully execute on our innovation strategy.

women harvesting tea leaves with basket

Corporate responsibility

Supporting the future of our business and the health and well-being of patients, people and communities around the world.

Explore our CR report

Download ESG Progress Report

We're led by our science

We follow the science to our next breakthrough, leaving no stone unturned.

View our stories

Our third-quarter 2020 financial results

Merck announced third-quarter worldwide sales of $12.6 billion – an increase of 1% compared with the third quarter of 2019. Excluding the impact from foreign exchange, sales grew 2%. The company anticipates full-year 2020 revenue range to be between $47.6 billion and $48.6 billion, including a negative impact from foreign exchange of approximately 1.5%. Take […]

Read more

Next: Our third-quarter 2020 financial results


Our new London Discovery Research Center site

The $1.32 billion, 220,000-square-foot research facility will be located in London’s “Knowledge Quarter”

Read more

Next: Our new London Discovery Research Center site


Clinical trials bring our medicines and vaccines to life

We appreciate all who have contributed to our clinical research

Read more

Next: Clinical trials bring our medicines and vaccines to life


Unsubscribe from email alerts

Contact us banner image
For questions, please contact our team.

Contact investor relations